26 Therapeutics Inc.
PrivateLast Round
Pre Seed
Mar 4, 2026
Company Overview
26 Therapeutics Inc. is a biotechnology company developing first-in-class topical small-molecule therapies for dry eye disease and meibomian gland disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
26 Therapeutics Inc. Comparables
Compare 26 Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OtusOphta Ltd. | 79% | |
| Novaliq | 76% | |
| Stuart Therapeutics, Inc. | 76% |
26 Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Mar 4, 2026 |
26 Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| adMare BioInnovations | Pre Seed |
26 Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about 26 Therapeutics Inc.'s valuation, stock price, and market status.
Is 26 Therapeutics Inc. a public or private company?
26 Therapeutics Inc. is a private company.
What is the current stock price of 26 Therapeutics Inc.?
26 Therapeutics Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is 26 Therapeutics Inc. worth (valuation)?
Valuation information for 26 Therapeutics Inc. is not publicly available.
Can I buy 26 Therapeutics Inc. stock?
26 Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was 26 Therapeutics Inc.'s last funding round?
26 Therapeutics Inc.'s most recent funding round was Pre Seed on March 4, 2026.
Who are the main investors in 26 Therapeutics Inc.?
Key investors in 26 Therapeutics Inc. include adMare BioInnovations.
Will 26 Therapeutics Inc. IPO soon?
No public IPO plans have been announced for 26 Therapeutics Inc..
How can I track 26 Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 26 Therapeutics Inc.'s secondary market activity and sign up for updates.